Literature DB >> 22178431

The production cost of anthelmintic resistance in lambs.

C M Miller1, T S Waghorn, D M Leathwick, P M Candy, A-M B Oliver, T G Watson.   

Abstract

The economic impact of anthelmintic resistance was investigated in lambs by comparing productivity parameters in groups of animals treated either with a highly effective anthelmintic, or an anthelmintic to which three species of resistant worms were known to be present. Ten farmlets, each stocked with 30 lambs, were rotationally grazed for 5 months, with monthly treatments of either albendazole, to which resistance existed, or a new combination product containing derquantel and abamectin (DQL-ABA) to which there was no resistance. Stock on five farmlets were treated with each anthelmintic and productivity measures, including liveweights, body condition and faecal soiling were assessed throughout. In addition, fleece weights and information on carcass weight and quality was collected at the end of the trial. Anthelmintic efficacy was measured at the last two treatment dates by faecal egg count reduction test with larval cultures. Albendazole demonstrated efficacies of 48.4% and 40.9% for Trichostrongylus spp. and Teladorsagia circumcincta respectively. By contrast, the DQL-ABA treatments were >99% effective against all genera. The difference in live-weight gain was 9 kg in favour of the DQL-ABA treatments. This translated into a 4.7 kg increase in carcass weight with a 10.4% increase in carcass value. Significant differences in body condition scores, faecal breech soiling and fleece weights were also recorded, all in favour of the DQL-ABA treatments. The time required for 50% of the animals to reach a target live-weight of 38 kg was significantly shorter (by 17 days) in those animals treated with DQL-ABA. The results show that the production cost of subclinical parasitism as a result of using an anthelmintic product which is less than fully effective due to resistance can greatly exceed the cost of routine testing of anthelmintic efficacy and the adoption of new anthelmintic classes. There is a strong case for many farmers to re-evaluate their position on some of these issues in order to optimise financial performance.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22178431     DOI: 10.1016/j.vetpar.2011.11.063

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  21 in total

1.  A comparative study of the effects of four treatment regimes on ivermectin efficacy, body weight and pasture contamination in lambs naturally infected with gastrointestinal nematodes in Scotland.

Authors:  Fiona Kenyon; David McBean; Andrew W Greer; Charlotte G S Burgess; Alison A Morrison; David J Bartley; Yvonne Bartley; Leigh Devin; Mintu Nath; Frank Jackson
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2013-03-06       Impact factor: 4.077

2.  Population replacement of benzimidazole-resistant Haemonchus contortus with susceptible strains: evidence of changes in the resistance status.

Authors:  Sebastián Muchiut; César Fiel; Juan Pedro Lirón; Mercedes Lloberas; Carolina Ceriani; Ramiro Lorenzo; Eliana Riva; Gisele Bernat; Patricia Cardozo; Silvina Fernández; Pedro Steffan
Journal:  Parasitol Res       Date:  2022-07-02       Impact factor: 2.383

3.  Polymorphisms in exon 11 of the mptl-1 gene and monepantel resistance in Haemonchus contortus.

Authors:  Simone Cristina Méo Niciura; Cintia Hiromi Okino; Alessandra da Silva Nucci; Wilson Malagó; Magda Vieira Benavides; Sergio Novita Esteves; Ana Carolina de Souza Chagas
Journal:  Parasitol Res       Date:  2022-10-04       Impact factor: 2.383

4.  Improving liveweight gain of lambs infected by multidrug-resistant nematodes using a FECRT-based schedule of treatments.

Authors:  Felipe Lamberti Pivoto; Fabricio Amadori Machado; Paulo Afonso Anezi-Junior; Augusto Weber; Alfredo Skrebsky Cezar; Luis Antonio Sangioni; Fernanda Silveira Flores Vogel
Journal:  Parasitol Res       Date:  2014-04-18       Impact factor: 2.289

5.  Economic viability of anthelmintic treatment in naturally infected beef cattle under different nutritional strategies after weaning.

Authors:  Fernanda Ramos; Camila Balconi Marques; Caroline Zamperete Reginato; Fernando de Souza Rodrigues; Luis Antônio Sangioni; Fernanda Silveira Flôres Vogel; Luciana Pötter
Journal:  Parasitol Res       Date:  2018-10-09       Impact factor: 2.289

6.  Anthelmintic activity of Eucalyptus staigeriana encapsulated oil on sheep gastrointestinal nematodes.

Authors:  Mayara de Aquino Mesquita; João Batista E Silva Júnior; Andressa Machado Panassol; Erick Falcão de Oliveira; Ana Lourdes Camurça Fernandes Vasconcelos; Haroldo Cesar Beserra de Paula; Claudia Maria Leal Bevilaqua
Journal:  Parasitol Res       Date:  2013-06-20       Impact factor: 2.289

7.  Evidence for reversion towards anthelmintic susceptibility in Teladorsagia circumcincta in response to resistance management programmes.

Authors:  Dave M Leathwick; Siva Ganesh; Tania S Waghorn
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2015-02-07       Impact factor: 4.077

8.  Signatures of selection in sheep bred for resistance or susceptibility to gastrointestinal nematodes.

Authors:  Kathryn M McRae; John C McEwan; Ken G Dodds; Neil J Gemmell
Journal:  BMC Genomics       Date:  2014-07-30       Impact factor: 3.969

9.  Protein profile of lambs experimentally infected with Haemonchus contortus and supplemented with selenium and copper.

Authors:  Guilherme Costa Fausto; Felipe Lamberti Pivoto; Márcio Machado Costa; Sônia Terezinha dos Anjos Lopes; Raqueli Teresinha França; Marcelo Beltrão Molento; Antonio Humberto Hamad Minervino; João Batista Teixeira da Rocha; Marta Lizandra do Rêgo Leal
Journal:  Parasit Vectors       Date:  2014-08-05       Impact factor: 3.876

Review 10.  Effect of gastro-intestinal nematode infection on sheep performance: a systematic review and meta-analysis.

Authors:  Fabien Mavrot; Hubertus Hertzberg; Paul Torgerson
Journal:  Parasit Vectors       Date:  2015-10-24       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.